These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16678751)

  • 1. The effects of external subretinal fluid drainage on secondary glaucoma in Coats' disease.
    Han ES; Choung HK; Heo JW; Kim SJ; Yu YS
    J AAPOS; 2006 Apr; 10(2):155-8. PubMed ID: 16678751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of moderate to advanced Coats' disease.
    Kiratli H; Eldem B
    Ophthalmologica; 1998; 212(1):19-22. PubMed ID: 9438579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and management of advanced Coats' disease.
    Silodor SW; Augsburger JJ; Shields JA; Tasman W
    Ophthalmic Surg; 1988 Feb; 19(2):89-93. PubMed ID: 3347463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitrectomy techniques in late-stage Coats'-like exudative retinal detachment.
    Yoshizumi MO; Kreiger AE; Lewis H; Foxman B; Hakakha BA
    Doc Ophthalmol; 1995; 90(4):387-94. PubMed ID: 8620821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total exudative retinal detachment in coats disease: biochemical analysis of the subretinal exudate.
    Hsu J; Forbes B; Maguire AM
    Retina; 2006 Sep; 26(7):831-3. PubMed ID: 16963863
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
    Bhat V; D'Souza P; Shah PK; Narendran V
    Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A; Shields CL
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on the management of Coats' disease: less is more.
    Adam RS; Kertes PJ; Lam WC
    Br J Ophthalmol; 2007 Mar; 91(3):303-6. PubMed ID: 17020897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.
    Shields JA; Shields CL; Honavar SG; Demirci H
    Am J Ophthalmol; 2001 May; 131(5):561-71. PubMed ID: 11336930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab.
    He YG; Wang H; Zhao B; Lee J; Bahl D; McCluskey J
    Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1519-21. PubMed ID: 20379736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of perfluorocarbon liquid in the surgical repair of a bullous retinal detachment secondary to Coats' disease.
    Devenyi RG
    Can J Ophthalmol; 1998 Dec; 33(7):385-6. PubMed ID: 9885755
    [No Abstract]   [Full Text] [Related]  

  • 12. Coats' disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease.
    Yousef YA; ElRimawi AH; Nazzal RM; Qaroot AF; AlAref AH; Mohammad M; Abureesh O; Rejdak R; Nowomiejska K; Avitabile T; Toro MD; AlNawaiseh I
    Medicine (Baltimore); 2020 Apr; 99(16):e19623. PubMed ID: 32311932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coats' syndrome as a cause of secondary open-angle glaucoma.
    Eibschitz-Tsimhoni M; Johnson MW; Johnson TM; Moroi SE
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):312-4. PubMed ID: 12875462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser treatment of Coats' disease.
    Couvillion SS; Margolis R; Mavrofjides E; Hess D; Murray TG
    J Pediatr Ophthalmol Strabismus; 2005; 42(6):367-8. PubMed ID: 16382562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes of Total Exudative Retinal Detachments in Stage 3B Coats Disease.
    Li AS; Capone A; Trese MT; Sears JE; Kychenthal A; De la Huerta I; Ferrone PJ
    Ophthalmology; 2018 Jun; 125(6):887-893. PubMed ID: 29361355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Coats' disease.
    Haik BG
    Trans Am Ophthalmol Soc; 1991; 89():371-476. PubMed ID: 1808814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coats' disease diagnosed in adulthood.
    Smithen LM; Brown GC; Brucker AJ; Yannuzzi LA; Klais CM; Spaide RF
    Ophthalmology; 2005 Jun; 112(6):1072-8. PubMed ID: 15882905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective photocoagulation in Coats' disease: ten-year follow-up.
    Nucci P; Bandello F; Serafino M; Wilson ME
    Eur J Ophthalmol; 2002; 12(6):501-5. PubMed ID: 12510719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT.
    Stanga PE; Jaberansari H; Bindra MS; Gil-Martinez M; Biswas S
    Retina; 2016 Jan; 36(1):156-62. PubMed ID: 26355946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual prognosis of Coats' disease.
    Budning AS; Heon E; Gallie BL
    J AAPOS; 1998 Dec; 2(6):356-9. PubMed ID: 10532724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.